1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Systemic Aspergillosis and Systemic Candidasis Market – By Type

1.3.2        North America Systemic Aspergillosis and Systemic Candidasis Market – By Application

1.3.3        North America Systemic Aspergillosis and Systemic Candidasis Market – By Country

2.           Systemic Aspergillosis And Systemic Candidasis Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Systemic Aspergillosis and Systemic Candidasis Market– Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Expert Opinions

4.4         Clinical Trials Phases of Products Offered by Companies

4.5         Candida Specific Products

5.           Systemic Aspergillosis and Systemic Candidasis Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rise in Prevalence of Fungal Diseases

5.1.2        Rising Hospital Acquired Fungal Infection

5.2         Market Restraints

5.2.1        Increasing Resistance to Antifungal Drugs

5.2.2        Side Effects of Antifungal Drugs

5.3         Market Opportunities

5.3.1        Increase in R&D Activities and Pipeline of New Drug

5.4         Future Trends

5.4.1        Consolidation of Market

5.5         Impact Analysis

6.           Systemic Aspergillosis and Systemic Candidasis Market Analysis– by Type

6.1         Overview

6.2         North America Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2019 and 2027 (%)

6.3         Voriconazole

6.3.1        Overview

6.3.2        North America Voriconazole Market Revenue and Forecasts to 2027 (US$ Mn)

6.4         Liposomal Amphotericin B

6.4.1        Overview

6.4.2        North America Liposomal Amphotericin B Market Revenue and Forecasts to 2027 (US$ Mn)

6.5         Systemic Oral Azoles

6.5.1        Overview

6.5.2        North America Systemic Oral Azoles Market Revenue and Forecasts to 2027 (US$ Mn)

6.6         Topical Antifungal Agents

6.6.1        Overview

6.6.2        North America Topical Antifungal Agents Market Revenue and Forecasts to 2027 (US$ Mn)

6.7         Others

6.7.1        Overview

6.7.2        North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

7.           Systemic Aspergillosis and Systemic Candidasis Market Analysis– by Application

7.1         Overview

7.2         North America Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2019 and 2027 (%)

7.3         Chronic Pulmonary Aspergillosis (CPA)

7.3.1        Overview

7.3.2        North America Chronic pulmonary aspergillosis (CPA) Market Revenue and Forecasts to 2027 (US$ Mn)

7.4         Allergic Bronchopulmonary Aspergillosis (ABPA)

7.4.1        Overview

7.4.2        North America Allergic bronchopulmonary aspergillosis (ABPA) Market Revenue and Forecasts to 2027 (US$ Mn)

7.5         Gastrointestinal Candidiasis

7.5.1        Overview

7.5.2        North America Gastrointestinal Candidiasis Market Revenue and Forecasts to 2027 (US$ Mn)

7.6         Genitourinary Tract Candidiasis

7.6.1        Overview

7.6.2        North America Genitourinary Tract Candidiasis Market Revenue and Forecasts to 2027 (US$ Mn)

7.7         Others

7.7.1        Overview

7.7.2        North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

8.           Systemic Aspergillosis and Systemic Candidiasis Market – Regional Analysis

8.1         Overview

8.1.1        North America: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.2        North America Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018–2027 (USD Million)

8.1.3        North America Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018–2027 (USD Million)

8.1.4        North America Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)

8.1.5        US: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.5.1          US: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.5.2          US: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018–2027 (USD Million)

8.1.5.3          US: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018–2027 (USD Million)

8.1.6        Canada: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.6.1          Canada: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.6.2          Canada: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018–2027 (USD Million)

8.1.6.3          Canada: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018–2027 (USD Million)

8.1.7        Mexico: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.7.1          Mexico: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.7.2          Mexico: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018–2027 (USD Million)

8.1.7.3          Mexico: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018–2027 (USD Million)

9.           Impact of COVID-19 Pandemic on North America Systemic Aspergillosis and Systemic Candidiasis Market

9.1         Impact Assessment of COVID-19 Pandemic

10.        COMPANY PROFILES

10.1      Novartis AG

10.1.1     Key Facts

10.1.2     Business Description

10.1.3     Products and Services

10.1.4     Financial Overview

10.1.5     SWOT Analysis

10.1.6     Key Developments

10.2      Sanofi

10.2.1     Key Facts

10.2.2     Business Description

10.2.3     Products and Services

10.2.4     Financial Overview

10.2.5     SWOT Analysis

10.2.6     Key Developments

10.3      Pfizer Inc.

10.3.1     Key Facts

10.3.2     Business Description

10.3.3     Products and Services

10.3.4     Financial Overview

10.3.5     SWOT Analysis

10.3.6     Key Developments

10.4      Merck & Co., Inc.

10.4.1     Key Facts

10.4.2     Business Description

10.4.3     Products and Services

10.4.4     Financial Overview

10.4.5     SWOT Analysis

10.4.6     Key Developments

10.5      Bayer AG

10.5.1     Key Facts

10.5.2     Business Description

10.5.3     Products and Services

10.5.4     Financial Overview

10.5.5     SWOT Analysis

10.5.6     Key Developments2

10.6      Astellas Pharma Inc.

10.6.1     Key Facts

10.6.2     Business Description

10.6.3     Products and Services

10.6.4     Financial Overview

10.6.5     SWOT Analysis

10.6.6     Key Developments6

10.7      GlaxoSmithKline plc.

10.7.1     Key Facts

10.7.2     Business Description

10.7.3     Products and Services

10.7.4     Financial Overview

10.7.5     SWOT Analysis

10.7.6     Key Developments

10.8      Abbott

10.8.1     Key Facts

10.8.2     Business Description

10.8.3     Products and Services

10.8.4     Financial Overview

10.8.5     SWOT Analysis6

10.8.6     Key Developments

10.9      Cipla Inc.

10.9.1     Key Facts

10.9.2     Business Description

10.9.3     Products and Services

10.9.4     Financial Overview

10.9.5     Key Developments

10.10   ENZON PHARMACEUTICALS, INC

10.10.1  Key Facts

10.10.2  Business Description

10.10.3  Products and Services

10.10.4  Financial Overview

10.10.5  SWOT Analysis

10.10.6  Key Developments

11.        Appendix4

11.1      About the Insight Partners

11.2      Glossary of Terms

LIST OF TABLES

Table 1.             Clinical Trials Phases of Products Offered by Companies

Table 2.             Candida Specific Products

Table 3.             Clinical cases of Candida auris reported by U.S. states, as of November 30, 2020

Table 4.             North America Systemic Aspergillosis and Systemic Candidiasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 5.             North America Systemic Aspergillosis and Systemic Candidiasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 6.             US: Systemic Aspergillosis and Systemic Candidiasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 7.             US: Systemic Aspergillosis and Systemic Candidiasis Market, by Application – Revenue and Forecast to 2027

Table 8.             Canada: Systemic Aspergillosis and Systemic Candidiasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 9.             Canada: Systemic Aspergillosis and Systemic Candidiasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 10.          Mexico: Systemic Aspergillosis and Systemic Candidiasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11.          Mexico: Systemic Aspergillosis and Systemic Candidiasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 12.          Glossary of Terms, Systemic Aspergillosis And Systemic Candidiasis Market4

LIST OF FIGURES

Figure 1.           Systemic Aspergillosis And Systemic Candidasis Market Segmentation

Figure 2.           Systemic Aspergillosis And Systemic Candidasis Market, By Region

Figure 3.           North America Systemic Aspergillosis And Systemic Candidasis Market Overview

Figure 4.           Systemic Oral Azoles Segment Held Largest Share of Type Segment In Systemic Aspergillosis And Systemic Candidasis Market

Figure 5.           Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           PEST Analysis

Figure 7.           Systemic Aspergillosis and Systemic Candidasis Market Impact Analysis of Drivers and Restraint

Figure 8.           North America Systemic Aspergillosis and Systemic Candidasis Market breakdown, by Type, 2019 and 2027 (%)

Figure 9.           North America Voriconazole Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 10.        North America Liposomal Amphotericin B Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        North America Systemic Oral Azoles Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        North America Topical Antifungal Agents Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        North America others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.        North America Systemic Aspergillosis and Systemic Candidasis Market breakdown, by Type, 2019 and 2027 (%)

Figure 15.        North America Chronic pulmonary aspergillosis (CPA) Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 16.        North America Allergic bronchopulmonary aspergillosis (ABPA)Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.        North America Gastrointestinal Candidiasis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        North America Genitourinary Tract Candidiasis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        North America others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.        North America: Systemic Aspergillosis and Systemic Candidiasis Market, by Key Country – Revenue (2019) (USD Million)

Figure 21.        North America: Systemic Aspergillosis and Systemic Candidiasis Market Revenue and Forecast to 2027 (USD Million)

Figure 22.        North America: Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)

Figure 23.        US: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 24.        Canada: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 25.        Mexico: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        Impact of COVID-19 Pandemic in North American Country Markets